The Centers for Disease Control and Prevention (CDC) has said that it’s investigating the possibility that Johnson & Johnson’s (J&J) COVID-19 vaccine can cause a rare neurological disorder known as Guillain-Barré syndrome (GBS). A spokesperson for the CDC told several news outlets on July 12 that the risk of developing the neurological disorder is very slim and is outweighed by the benefits of the J&J vaccine. The agency is investigating reports linking the vaccine to GBS, the spokesperson noted. “Reports of GBS after receipt of the J&J/Janssen COVID-19 Vaccine in the Vaccine Adverse Event Reporting System (VAERS) are rare, but do likely indicate a small possible risk of this side effect following this vaccine,” the CDC spokesperson said. “Around 100 preliminary reports of GBS have been detected in VAERS after 12.8 million doses of J&J/Janssen COVID-19 Vaccine administered. These cases have largely been reported about two weeks after vaccination and mostly …